Pfizer, Novartis, BMS, Lilly and others targeted in FDA’s TV ad crackdownnews2025-09-16T19:27:05+00:00September 16th, 2025|Endpoints News|
Ark, Atom file to go public in Hong Kong; Aptevo’s stock rallies on AML datanews2025-09-16T14:58:22+00:00September 16th, 2025|Endpoints News|
Eli Lilly picks Virginia for $5B API site as part of $27B US pledgenews2025-09-16T14:30:17+00:00September 16th, 2025|Endpoints News|
Post-Hoc Live: How to determine which digital health tools are worth the costnews2025-09-16T13:50:37+00:00September 16th, 2025|Endpoints News|
Dualitas gets $65M in Series A to develop bispecifics for immunologynews2025-09-16T11:00:54+00:00September 16th, 2025|Endpoints News|
AI biotech Synthesize Bio launches with $10M seed roundnews2025-09-16T11:00:27+00:00September 16th, 2025|Endpoints News|
Former CinCor executives launch Juca Bio and AllRock Bio for PAHnews2025-09-16T11:00:23+00:00September 16th, 2025|Endpoints News|
CSL spends $117M to support development of VarmX’s blood clotting drugnews2025-09-16T10:42:02+00:00September 16th, 2025|Endpoints News|
GHO Capital buys Scientist.com, provider of a drug development marketplacenews2025-09-16T10:00:46+00:00September 16th, 2025|Endpoints News|
Virtual ways to treat opioid use disorder don’t save much money, report findsnews2025-09-16T10:00:05+00:00September 16th, 2025|Endpoints News|
